safety
Kinase Profiling & Screening: Choosing a Biochemical Assay Platform
June 09 by Pharmaceuticals & Biotechnology EditorNot all kinase assays are created equally. What are the major differences between activity assays and binding assays? Radiometric platforms and other formats? Protein and peptide substrates? Labelle...
Top international hospitals to hold summit in Asia to address efficiency, patient safety issues
December 05 by Hospital Efficiency & Quality Asia Summit 2014The growing concern over patient safety is at the heart of every serious discussion among healthcare providers across Asia. According to World Health Organisation (WHO), “nearly one in ten pat...
An Image Problem in Biopharm?
October 17 by Tony HitchcockOver recent weeks I have been intrigued to hear some highly negative comments from people outside of the biopharm community on the industries economic value and also concerns regarding the public pe...
4 Key Criteria to Consider when Outsourcing Safety Operations in Life Sciences Facilities
September 10 by Jones Lang LaSalleAs life sciences organizations outsource more of their non-core activities, the safety systems associated with those functions become increasingly complex. Managing safety requires a set of capabili...
Pathogen Safety Summit 2013
August 09 by Pharma IQThe effect of pathogen-contaminated medicines hits home when assessing the consequences of last year’s medically-induced meningitis outbreak in America. Over 60 people died and up to 14,000 we...
Message from the Regulators: Pharmacovigilance to Move Heavily into Risk-Benefit Assessment
November 25 by Pharma IQPilar Carrero Director of Safety Medical Writing at Novo Nordisk, joins Andrea Charles from Pharma IQ, to discuss the impact social media has had on drug safety and risk managment and the dawn...
Bringing Innovation to Clinical Design
September 28 by Pharma IQClinical trials may be one of the most fundamental parts of drug development work carried out in the pharmaceutical industry, but they still remain a complicated area for pharma companies to address....